{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:30:12Z","timestamp":1777858212937,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p>This paper reviews the evidence for the efficacy of anticonvulsants in the\n                continuation and maintenance phases of treatment of bipolar disorder, when there has\n                been an episode of mania (Bipolar-I disorder). The evidence to be considered is\n                primarily that arising from randomized controlled trials.<\/jats:p>\n                  <jats:p>A literature search was performed to identify all randomized controlled trials of\n                anticonvulsants used as maintenance treatment for bipolar-I disorder.\n                Placebo-controlled studies were preferred, however there have been relatively few of\n                these and clinical practice must therefore be guided by evidence carrying a lower\n                level of conviction.<\/jats:p>\n                  <jats:p>Valproate monotherapy lacks a convincing evidence base. The view that valproate is\n                more effective than lithium in rapid cycling has not been borne out. Lamotrigine is\n                effective in preventing depression after an episode of mania. As monotherapy,\n                lithium appears superior to carbamazepine in bipolar patients not previously treated\n                with either drug. The combination of lithium and carbamazepine may be superior to\n                either drug alone, in certain treatment-resistant patients, but is associated with\n                increased side effects. Other anticonvulsants lack evidence supporting their use in\n                bipolar disorder except in treating co-morbid alcohol dependence, anxiety and\n                bulimic symptoms.<\/jats:p>\n                  <jats:p>Valproate continues to be recommended by most current guidelines despite the lack of evidence.<\/jats:p>","DOI":"10.1177\/1359786806063073","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T07:32:58Z","timestamp":1142926378000},"page":"23-30","source":"Crossref","is-referenced-by-count":4,"title":["The use of anticonvulsants in the aftermath of mania"],"prefix":"10.1177","volume":"20","author":[{"given":"John","family":"Cookson","sequence":"first","affiliation":[{"name":"The Royal London Hospital, St Clement\u2019s, London, UK, John.Cookson@ELCMHT.NHS.UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Elliott","sequence":"additional","affiliation":[{"name":"Johnson Unit (PICU), The Ladywell Unit, Lewisham University Hospital,\r                        London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0204"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.7.782"},{"issue":"426","key":"e_1_2_1_4_1","first-page":"13","article-title":"Valproate in bipolar disorder: 2000 onwards","volume":"111","year":"2005","unstructured":"Bowden C L, Singh V (2005) Valproate in bipolar disorder: 2000 onwards. Acta Psychitar Scand111 (Suppl. 426): 13-20","journal-title":"Acta Psychitar Scand"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.4.431"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"e_1_2_1_11_1","first-page":"2151","article-title":"A 20 month, double-blind, maintenance trial of lithium versus divalproex in\n                        rapid cycling bipolar disorder","volume":"162","year":"2005","unstructured":"Calabrese J, Shelton M, Rapport D, Youngstrom E, Shirley E, Elhaj O, Packer K, Bilali S, Findling R (2005) A 20 month, double-blind, maintenance trial of lithium versus divalproex in rapid cycling bipolar disorder. Am J Psychiatry162: 2151-2161","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.3.378"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb10890.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1102"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.12"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1103"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017002003"},{"issue":"290","key":"e_1_2_1_19_1","first-page":"1467","article-title":"Suicide risk in bipolar disorder during treatment with lithium and divalproex","volume":"17","year":"2003","unstructured":"Goodwin F K, Fireman B, Simon G E, Hunkeler E M, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA17(290): 1467-1473","journal-title":"JAMA"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0321"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00003"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00002"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0206"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1208"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1109"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb10273.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3"},{"issue":"419","key":"e_1_2_1_29_1","first-page":"1","article-title":"Psychopharmacological treatment with lithium and antiepileptic drugs:\n                        suggested guidelines from the Danish Psychiatric Association and the Child\n                        and Adolescent Psychiatric Association in Denmark","volume":"108","year":"2003","unstructured":"Licht R W, Vestergaard P, Kessing L V, Larsen J K, Thomsen P H (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand108 (Suppl. 419): 1-22","journal-title":"Acta Psychiatr Scand"},{"issue":"426","key":"e_1_2_1_30_1","first-page":"21","article-title":"Lamotrigine and antiepileptic drugs as mood stabilisers in bipolar disorders","volume":"111","year":"2005","unstructured":"Muzina D J, Elhaj O, Gajwani P, Gao K, Calabrese J R (2005) Lamotrigine and antiepileptic drugs as mood stabilisers in bipolar disorders. Acta Psych Scand111 (Suppl. 426): 21-28","journal-title":"Acta Psych Scand"},{"key":"e_1_2_1_31_1","volume-title":"Richtlijn bipolaire stoornissen (Guideline Bipolar\n                disorders)","year":"2001","unstructured":"Nolen W A, Knoppert-van der Klein E A M, Honig A, Bouvy P F, Klompenhouwer J-L, De Witt A, Ravelli D P (2001) Richtlijn bipolaire stoornissen (Guideline Bipolar disorders). Boom Publishers, Amsterdam"},{"key":"e_1_2_1_32_1","first-page":"283","article-title":"Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic\n                        depressive psychosis: a preliminary report","volume":"27","year":"1973","unstructured":"Okuma T, Kishimoto A, Inoue K, Matumoto A, Ogura A, Matsushita T, Nakao T, Ogura C (1973) Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatrica Neurology Japan27: 283-297","journal-title":"Folia Psychiatrica Neurology Japan"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431111"},{"issue":"3","key":"e_1_2_1_34_1","first-page":"249","article-title":"Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive\n                        therapy. Gabapentin Bipolar Disorder Study Group","volume":"2","year":"2000","unstructured":"Pande A C, Crockatt J G, Janney C A, Werth J L, Tsaroucha G (2000) Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord2(3 Pt 2): 249-255","journal-title":"Bipolar Disord"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"e_1_2_1_36_1","first-page":"227","article-title":"Prophylaxis of bipolar disorders","volume":"2","year":"1990","unstructured":"Post R M (1990) Prophylaxis of bipolar disorders. International Review of Psychiatry2: 227-320","journal-title":"International Review of Psychiatry"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.8.999"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.12.1602"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.7.840"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750330035006"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00088.x"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00107.x"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.37"},{"key":"e_1_2_1_43_1","first-page":"1604","article-title":"Lithium-carbamazepine neurotoxicity and risk factors","volume":"141","year":"1985","unstructured":"Shukla S, Godwin C D, Long L E B, Miller M G (1985) Lithium-carbamazepine neurotoxicity and risk factors. American Journal of Psychiatry141: 1604-1606","journal-title":"American Journal of Psychiatry"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0301"},{"key":"e_1_2_1_45_1","first-page":"336","article-title":"Lithium- and carbamazepine-associated sinus node dysfunction: nine-year\n                        experience in a psychiatric hospital","volume":"14","year":"1994","unstructured":"Steckler T L (1994) Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. Journal of Clinical Psychopharmacology14: 336-339","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0710"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"issue":"3","key":"e_1_2_1_49_1","first-page":"5","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for\n                        the management of patients with bipolar disorder: consensus and controversies","volume":"7","year":"2005","unstructured":"Yatham L N, Kennedy S H, O\u2019Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young T, Ravindran A, Schaffer A, Connolly M, Gorman C P (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord7 (Suppl. 3): 5-69","journal-title":"Bipolar Disord"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1210"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1359786806063073","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1359786806063073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:09:47Z","timestamp":1777507787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1359786806063073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":50,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1177\/1359786806063073"],"URL":"https:\/\/doi.org\/10.1177\/1359786806063073","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}